CClinicalTrials.gg
CompletedNCT06019442Updated Feb 9, 2024

An Electronic Brief Alcohol Intervention for Women Attending a Breast Screening Service (Health4Her)

An interventional study of Brief alcohol intervention (Health4Her-Automated) and Lifestyle health promotion in Health Knowledge, Attitudes, Practice and Alcohol Drinking, sponsored by Turning Point. Completed at 1 site in Australia. Open to female participants aged 40 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-09.

Sponsored by Turning Point · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
143
Allocation
Randomized
Ages
40 Years and older
Sex
Female
01

Study summary

Alcohol is a major modifiable risk factor for female breast cancer; yet, awareness of this risk remains surprisingly low and is not systematically addressed in healthcare settings. This study aim to test the effectiveness of a co-designed, automated brief alcohol intervention (Health4Her-Automated) in reducing women's drinking intentions, improving alcohol literacy, and reducing consumption.

Read the detailed description

Alcohol is a major modifiable risk factor for female breast cancer, even in very low amounts. In Australia, alcohol consumption accounts for 6.6 per cent of cases in post-menopausal women, and 18 per cent of breast cancer deaths. Yet, awareness of this risk remains low and is not systematically addressed in healthcare settings. Embedding a brief alcohol intervention within lifestyle information offered to all women attending breast screening provides the opportunity to address harmful drinking in a discrete, non-judgmental way, to prevent alcohol-attributable breast cancer among this at-risk population.

Brief alcohol interventions are short, single-session programs typically offered in general practice settings to gather information on a person's alcohol consumption and, in a non confrontational way, provide strategies and motivate change to reduce consumption and related risk of harm. An automated brief alcohol intervention, self-completed on a device such as an iPad, is a low-cost, labour- and time-efficient approach that overcomes many of the issues of providing intervention within busy healthcare environments.

Building on the previous pilot trial of a prototype brief e-health intervention (which included alcohol-related questions asked by a researcher, and an animation viewed on an iPad that was activated by the researcher), the aim of the current study is to test the effectiveness of a co-designed, automated brief alcohol intervention (Health4Her-Automated) in reducing women's drinking intentions, improving alcohol literacy, and reducing consumption.

02

Conditions studied

  • Health Knowledge, Attitudes, Practice
  • Alcohol Drinking

Browse trials for

Keywords

  • Women's health
  • Public health
  • Health promotion
03

In context

Alcohol Drinking

925 studies on the registry are indexed under Alcohol Drinking; 172 are open to participants now.

This study's enrollment of 143 is above the median of 108 across 802 interventional studies indexed under Alcohol Drinking.

Browse Alcohol Drinking studies →

Lead sponsor

Turning Point is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Female
  • 40+ years of age
  • Attending routine breast screening
  • With or without a breast cancer history
  • Reporting any level of alcohol consumption

Exclusion criteria

Exclusion Criteria:

  • Not able to read or comprehend English to enable participation
  • No access to a computer, tablet or smartphone to complete follow-up assessment
  • Women who are pregnant (also an exclusion from breast screening)
  • Participation in the pilot Health4Her trial
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
143 participants (actual)

Study arms

  • Experimental
    Brief alcohol intervention (Health4Her-Automated) + lifestyle health promotion

    The intervention arm will receive: * brief alcohol intervention * lifestyle health promotion focused on physical activity and maintaining a healthy weight for reducing breast cancer risk. Participants will receive an iPad and earphones to self-complete the intervention. Alcohol and lifestyle information will be delivered by way of an animation on an iPad, and self-completed activities to reinforce intervention content.

    Behavioral: Brief alcohol intervention (Health4Her-Automated) · Behavioral: Lifestyle health promotion

  • Other
    Lifestyle health promotion

    The control arm will receive: * lifestyle health promotion focused on physical activity and maintaining a healthy weight for reducing breast cancer risk. Participants will receive an iPad and earphones to self-complete the control intervention. Lifestyle information will be delivered by way of an animation on an iPad, and a self-completed activity to reinforce intervention content.

    Behavioral: Lifestyle health promotion

Interventions

  • BehavioralBrief alcohol intervention (Health4Her-Automated)

    Embedded within the lifestyle health promotion provided in both conditions, participants randomised to the experimental condition will receive a brief alcohol intervention. The brief alcohol intervention will comprise information and behaviour-change content regarding alcohol consumption, including: messaging around alcohol risks/harms (with a focus on alcohol use and breast cancer risk), positive-framed messaging on the health benefits of reducing alcohol intake, and alcohol harm-reduction / behaviour change strategies (e.g. drink counting, goal setting, behaviour substitution, problem solving). Post-session information will be provided via email (i.e. electronic brochure summarising brief alcohol intervention content).

  • BehavioralLifestyle health promotion

    Lifestyle health promotion, focused on physical activity and maintaining a healthy weight for reducing breast cancer risk, will be provided. Post-session information will be provided via email (i.e. electronic brochure summarising nutrition for maintaining a healthy weight).

06

What researchers measure

Primary outcomes

  1. Drinking intentions

    Change in next-month drinking intentions (5-point scale: 1, not at all; 5, to a very large extent)

    Time frame: immediately post-randomisation

Secondary outcomes

  1. Drinking intentions

    Change in next-month drinking intentions (5-point scale: 1, not at all; 5, to a very large extent)

    Time frame: 4-weeks post-randomisation

  2. Drinking intentions - standard drinks

    Change in intended number of standard drinks consumed over the next month (composite of intention frequency/quantity response items)

    Time frame: 4-weeks post-randomisation

  3. Proportion of participants intending to reduce alcohol consumption

    Proportion of participants intending to reduce their next-month alcohol consumption (5-point scale: 1, not at all; 5, to a very large extent)

    Time frame: immediately post-randomisation

  4. Proportion of participants intending to reduce alcohol consumption

    Proportion of participants intending to reduce their next-month alcohol consumption (5-point scale: 1, not at all; 5, to a very large extent)

    Time frame: 4-weeks post-randomisation

  5. Knowledge of alcohol as a breast cancer risk factor

    Proportion of participants accurately identifying alcohol as a clear risk factor for breast cancer

    Time frame: 4-weeks post-randomisation

  6. Alcohol literacy

    Proportion of participants accurately identifying i) the increased breast cancer risk associated with drinking one average restaurant serve of wine a day; ii) the number of standard drinks in an average restaurant serve of red wine; iii) the maximum number of standard drinks per week recommended by current Australian Alcohol Guidelines (multiple-choice questions)

    Time frame: 4-weeks post-randomisation

  7. Alcohol consumption

    Among women who have had an alcohol drink in the past month, change in alcohol consumption (composite of frequency/quantity response items)

    Time frame: 4-weeks post-randomisation

  8. Knowledge of other breast cancer risk factors

    Proportion of participants accurately identifying inactivity and excess weight as risk factors for breast cancer

    Time frame: 4-weeks post-randomisation

07

Study locations

1 site
  • Maroondah BreastScreen
    Ringwood East, Victoria 3135, Australia
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Aug 11, 2023
  • Statistical analysis plan · Feb 7, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — There is not Ethics approval to seek patient permission to share data outside this study.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06019442
Lead sponsor
Turning Point
Collaborators
Monash University, Eastern Health, BreastScreen Victoria, Lifepool, Shades of Pink
Responsible party
Sponsor
First posted
Aug 31, 2023
Start date
Sep 1, 2023
Primary completion
Oct 6, 2023
Completion
Dec 1, 2023
Last update
Feb 9, 2024

Study contacts

Jasmin Grigg, PhD
principal investigator · Turning Point, Eastern Health; Monash University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion